GlaxoSmithKline Capital PLC Publication of Final Terms (3404M)
07 Mayo 2020 - 11:43AM
UK Regulatory
TIDMAG99 TIDMGSK
RNS Number : 3404M
GlaxoSmithKline Capital PLC
07 May 2020
Issued: 7 May 2020, London UK - LSE Announcement
Publication of Final Terms
The following final terms dated 7 May 2020 (the "Final Terms")
in respect of the Notes (as defined below) are available for
viewing:
GlaxoSmithKline Capital plc issue of:
GBP 750,000,000 1.250 per cent. Notes due 12 October 2028;
GBP 750,000,000 1.625 per cent. Notes due 12 May 2035; and
EUR 750,000,000 0.125 per cent. Notes due 12 May 2023,
in each case guaranteed by GlaxoSmithKline plc issued under the
GBP20,000,000,000 Euro Medium Term Note Programme (the "Notes")
Copies of the Final Terms have been submitted to the UK Listing
Authority's NSM submission portal via the Electronic Submission
System (ESS). A copy can be viewed at:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
GlaxoSmithKline Capital plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Enquiries:
UK Media enquiries: David Mawdsley (020) 8047 5564
Simon Steel (020) 8047 3763
European Analyst/Investor
enquiries: James Dodwell (020) 8047 2406
Danielle Smith (020) 8047 0932
BASIS ON WHICH YOU MAY ACCESS THE FINAL TERMS AND BASE
PROSPECTUS
Please note that the information contained in the Final Terms
and the Base Prospectus may be addressed to and/or targeted at
persons who are residents of particular countries (specified in the
Base Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Final Terms is not addressed. Prior to
relying on the information contained in the Final Terms or the Base
Prospectus you must ascertain from the Base P rospectus whether or
not you are part of the intended addressees of the information
contained therein.
Your right to access this service is conditional upon complying
with the above requirements.
GlaxoSmithKline plc
Registered in England & Wales:
No. 3888792
Registered Office:
980 Great West Road
Brentford, Middlesex
TW8 9GS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
PFTBLGDUCXGDGGR
(END) Dow Jones Newswires
May 07, 2020 12:43 ET (16:43 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024